Why would they even bother?
What am I missing here?
The data is out there on the effectiveness of Oral dosing, the levels to be effective would surely introduce the issues seen in the past by others using PPS
Good to see others see the potential of PPS, stuff we already know, I can't help but feel that not enough people in the field really know what PAR are up to, how far they come, and the data we already have on all of this (thanks Mozz)
Just hope we get ours out the door before they potentially have some bad press with PPS causing people some issues with the oral route.
Why would they even bother?What am I missing here?The data is...
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
-0.005(1.92%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.0¢ | 25.5¢ | $261.4K | 990.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 9445 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |